EPS for Magellan Health (MGLN) Expected At $0.94, Last Week Atlantica Yield PLC (ABY) Analysts

July 19, 2017 - By Adrian Erickson

Among 4 analysts covering Abengoa Yield (NASDAQ:ABY), 0 have Buy rating, 1 Sell and 3 Hold. Therefore 0 are positive. Abengoa Yield had 9 analyst reports since August 3, 2015 according to SRatingsIntel. The company was maintained on Tuesday, August 11 by Canaccord Genuity. The firm has “Outperform” rating by RBC Capital Markets given on Monday, August 3. Canaccord Genuity downgraded the shares of ABY in report on Monday, November 30 to “Hold” rating. The firm earned “Neutral” rating on Tuesday, September 8 by Bank of America. The rating was downgraded by Bank of America to “Underperform” on Monday, November 30. The firm has “Equal-Weight” rating given on Wednesday, September 30 by Morgan Stanley. See Atlantica Yield PLC (NASDAQ:ABY) latest ratings:

12/04/2017 Broker: Jefferies Rating: Hold New Target: $22.00 Initiates Coverage On

Analysts expect Magellan Health Inc (NASDAQ:MGLN) to report $0.94 EPS on July, 28 before the open.They anticipate $0.48 EPS change or 104.35% from last quarter’s $0.46 EPS. MGLN’s profit would be $22.08M giving it 20.84 P/E if the $0.94 EPS is correct. After having $0.74 EPS previously, Magellan Health Inc’s analysts see 27.03% EPS growth. It closed at $78.35 lastly. It is down 5.31% since July 19, 2016 and is uptrending. It has underperformed by 11.39% the S&P500.

Among 4 analysts covering Magellan Health (NASDAQ:MGLN), 3 have Buy rating, 1 Sell and 0 Hold. Therefore 75% are positive. Magellan Health had 14 analyst reports since July 29, 2015 according to SRatingsIntel. Jefferies maintained the shares of MGLN in report on Monday, September 26 with “Buy” rating. The stock of Magellan Health Inc (NASDAQ:MGLN) earned “Buy” rating by Jefferies on Friday, May 20. The firm has “Underweight” rating by Barclays Capital given on Wednesday, November 23. On Tuesday, August 11 the stock rating was maintained by Scotia Capital with “Sector Perform”. The rating was maintained by Leerink Swann on Friday, June 23 with “Buy”. As per Wednesday, June 7, the company rating was maintained by Jefferies. Barclays Capital downgraded Magellan Health Inc (NASDAQ:MGLN) on Wednesday, January 6 to “Underweight” rating. KeyBanc Capital Markets upgraded Magellan Health Inc (NASDAQ:MGLN) on Friday, July 14 to “Overweight” rating.

Investors sentiment increased to 0.97 in Q4 2016. Its up 0.06, from 0.91 in 2016Q3. It increased, as 14 investors sold Magellan Health Inc shares while 81 reduced holdings. 40 funds opened positions while 52 raised stakes. 21.43 million shares or 3.41% more from 20.72 million shares in 2016Q3 were reported. National Bank & Trust Of America De owns 43,639 shares for 0% of their portfolio. Moreover, Alpha Windward Ltd Co has 0.33% invested in Magellan Health Inc (NASDAQ:MGLN) for 6,780 shares. Guggenheim Llc invested in 29,759 shares or 0.01% of the stock. Nomura Asset Mgmt Company stated it has 0% in Magellan Health Inc (NASDAQ:MGLN). Hillsdale Invest Incorporated reported 13,500 shares or 0.21% of all its holdings. Perceptive Advsrs Ltd holds 0.04% of its portfolio in Magellan Health Inc (NASDAQ:MGLN) for 7,508 shares. Orbimed Advsr Ltd Liability Co holds 801,600 shares. Walleye Trading Ltd Limited Liability Company invested in 2,200 shares or 0% of the stock. Verition Fund Ltd Liability Corporation holds 0.02% of its portfolio in Magellan Health Inc (NASDAQ:MGLN) for 3,107 shares. Cantab Prtnrs Llp invested in 18,207 shares or 0% of the stock. Oxford Asset Mgmt holds 0.12% or 33,243 shares. Sentinel Asset Management reported 0.31% of its portfolio in Magellan Health Inc (NASDAQ:MGLN). 105,500 were reported by Cornerstone Cap Management Limited Liability Company. Art Ltd has 0.09% invested in Magellan Health Inc (NASDAQ:MGLN). The United Kingdom-based Barclays Public Limited Com has invested 0% in Magellan Health Inc (NASDAQ:MGLN).

Magellan Health, Inc. is engaged in the healthcare management business. The company has market cap of $1.84 billion. The Company’s divisions include Healthcare, Pharmacy Management and Corporate. It has a 22.64 P/E ratio. It is focused on managing special populations, complete pharmacy benefits and other specialty areas of healthcare.

Since February 1, 2017, it had 0 insider buys, and 4 selling transactions for $2.88 million activity. WEST JEFFREY N sold $254,451 worth of Magellan Health Inc (NASDAQ:MGLN) on Wednesday, February 1. Shares for $389,360 were sold by BROSHY ERAN on Thursday, February 23.